---
annotations:
- type: Pathway Ontology
  value: coagulation cascade pathway
authors:
- MaintBot
- Khanspers
- Ariutta
- ReactomeTeam
- Anwesha
- Mkutmon
description: The formation of a fibrin clot at the site of an injury to the wall of
  a normal blood vessel is an essential part of the process to stop blood loss after
  vascular injury.  The reactions that lead to fibrin clot formation are commonly
  described as a cascade, in which the product of each step is an enzyme or cofactor
  needed for following reactions to proceed efficiently.  The entire clotting cascade
  can be divided into three portions, the extrinsic pathway, the intrinsic pathway,
  and the common pathway.  The extrinsic pathway begins with the release of tissue
  factor at the site of vascular injury and leads to the activation of factor X.  The
  intrinsic pathway provides an alternative mechanism for activation of factor X,
  starting from the activation of factor XII.  The common pathway consists of the
  steps linking the activation of factor X to the formation of a multimeric, cross-linked
  fibrin clot.  Each of these pathways includes not only a cascade of events that
  generate the catalytic activities needed for clot formation, but also numerous positive
  and negative regulatory events.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=140877
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP1818
- /instance/WP1818
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP1818.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The formation of a fibrin clot at the site of an injury to the wall
    of a normal blood vessel is an essential part of the process to stop blood loss
    after vascular injury.  The reactions that lead to fibrin clot formation are commonly
    described as a cascade, in which the product of each step is an enzyme or cofactor
    needed for following reactions to proceed efficiently.  The entire clotting cascade
    can be divided into three portions, the extrinsic pathway, the intrinsic pathway,
    and the common pathway.  The extrinsic pathway begins with the release of tissue
    factor at the site of vascular injury and leads to the activation of factor X.  The
    intrinsic pathway provides an alternative mechanism for activation of factor X,
    starting from the activation of factor XII.  The common pathway consists of the
    steps linking the activation of factor X to the formation of a multimeric, cross-linked
    fibrin clot.  Each of these pathways includes not only a cascade of events that
    generate the catalytic activities needed for clot formation, but also numerous
    positive and negative regulatory events.  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=140877
    Reactome].
  keywords:
  - (329-615)
  - multimer
  - acidic polypeptide
  - factor multimer
  - 'GAG '
  - 'PalmC-F3 '
  - F9(29-461)
  - 'GP1BB '
  - 'factor VIIa heavy chain '
  - Factor Xa inhibitors
  - 11xCbxE-PROS1
  - factor VIIIa with
  - factor VIIIa
  - 'C1QBP '
  - 'F12 T328K '
  - 'KLKB1(20-638) '
  - factor VIIIa:factor
  - kallikrein:alpha2-macroglobulin
  - 'dalteparin '
  - 'factor XI monomer '
  - 'F12 T328R (373-615) '
  - TFPI:TF:F7a:factor
  - '10xCbxE-F7(61-212) '
  - factor VIIa
  - 'KLKB1(391-638) '
  - 'FGG '
  - 'GP9 '
  - 'factor XIII A chain '
  - thrombin:thrombomodulin
  - Inactivated factor
  - Plasma kallikrein
  - F12 variant (20-328)
  - 'F8(392-759) R550G '
  - TF:F7
  - Extracellular
  - IIa):SERPIND1
  - 'PRTN3 '
  - 'FGB(31-491) '
  - 'PROC(212-461) '
  - 12xCbxE-3D-F9(47-461)
  - 'apixaban '
  - 'PF4V1(31-104) '
  - factor XI
  - (compounds):IIa
  - (peptide):IIa
  - thrombin
  - 'factor Va light chain '
  - Ca2+
  - Bradykinin
  - GAG
  - variant:A3-C1-C2
  - F8(356-372)
  - F8(582-640)
  - 'SERPING1 '
  - VIII
  - SERPINC1 activators
  - sequestered tissue
  - 'GP1BA '
  - 10xCbxE-F7(61-466):Ca2+
  - (compounds)
  - factor XII
  - kallikrein:kininogen:C1q binding protein tetramer
  - Platelet Factor 4
  - von Willibrand
  - PROCR(18-?):PRTN3:CD177
  - 'bivalirudin '
  - A1:A3-C1-C2
  - PROCR(18-?)
  - polypeptide
  - 'CD177 '
  - 'F8(392-759) R717W '
  - 'VWF(764-2813) '
  - Willebrand factor
  - factor XIII
  - factor XI:GPIb-IX-V
  - factor VIII
  - protein C:F2R
  - 'F2R '
  - factor Vi
  - 'factor VIIIa A2 polypeptide '
  - SERPING1
  - defective A2 domain
  - factor VIIIa A2
  - factor XIIa
  - fibrin multimer
  - FGA(20-35)
  - Factor VIII
  - GPIb-IX-V
  - FVIIIa:FIXa R384L
  - F8(392-759) A2
  - FVIIIa:FIXa:PROS1
  - thrombin:SERPINC1:SERPINC1 activators
  - 'PRCP '
  - '11xCbxE-PROS1 '
  - inhibitors
  - (peptide)
  - 'F8(392-759) R550H '
  - 'factor XIIIa A chain '
  - PROC(200-211)
  - factor XIII A chain
  - 'KNG1(390-644) '
  - factor XIIa:C1Inh
  - 'F5(29-334) '
  - inhibitors:IIa
  - F5(535-737)
  - '10xCbxE-F7(61-466) '
  - 'thrombin light chain '
  - '8xCbxE-3D-PROC(43-197) '
  - 'GP5 '
  - 'Ca2+ '
  - 'SERPINC1(426-464) '
  - inactivating
  - kininogen:C1q
  - '12xCbxE-3D-F9(47-191) '
  - factor Va
  - 'KLKB1(20-390) '
  - Factor IIa
  - factor V activation
  - XIa:GPIb:GPIX:GPV
  - SERPIND1
  - TFPI
  - 'F12 T328R(20-328) '
  - factor VIIIa B A3
  - PROCR(18-?):Activated protein C
  - 'factor Xa heavy chain '
  - 'factor Va heavy chain '
  - 'F13B '
  - factor XIII cleaved
  - SERPINC1:SERPINC1
  - 'SERPINA5 '
  - 'SERPIND1 '
  - activators
  - SERPINA5
  - SERPINA5:Activated
  - Activated protein
  - 'F5(29-534) '
  - activation peptide
  - 'factor XIa heavy chain '
  - F2R
  - fibrin multimer,
  - 'F8(392-759) R550C '
  - 'KNG1(19-380) '
  - 10xCbxE-F2(44-622)
  - defective A1 domain
  - KLKB1(20-638)
  - 'factor VIIIa A1 polypeptide '
  - FGB(31-44)
  - THBD
  - PalmC-F3
  - factor XIIIa
  - 'TFPI '
  - 'FGA '
  - 'factor XIIa heavy chain '
  - 'F12 T328R (329-615) '
  - F13B
  - 'F12 T328K (373-615) '
  - 'PROCR(18-?) '
  - (373-615)
  - 'SERPINE2 '
  - thrombin:cleaved
  - 'A2M '
  - F5(335-534)
  - factor X activation
  - 'factor X heavy chain '
  - factor X
  - Va:Xa
  - factor VIII:von
  - Protein C
  - 'F8(20-355) '
  - 'factor XIIa light chain '
  - Fibrinogen
  - complex
  - KNG:C1q binding
  - 'FGB '
  - crosslinked
  - protein C
  - fibrin monomer
  - KNG1(19-644)
  - protein tetramer
  - 'PROC(200-461) '
  - 'PROCR '
  - SERPINE2:GAG:activated thrombin (factor IIa)
  - factor Xa:Factor Xa
  - C:Protein S
  - 'SERPINC1(33-425) '
  - 'thrombin heavy chain '
  - factor V
  - 'F9(227-461) R384L '
  - factor
  - precursor
  - 'factor IXa heavy chain '
  - 'factor VIII light chain '
  - 'F12 T328K (329-615) '
  - PRTN3:CD177
  - prolylcarboxypeptidase dimer
  - 'F8(392-759) R717L '
  - tetramer
  - factor IXa
  - 'THBD '
  - 'PF4(32-101) '
  - activated thrombin
  - 'F8(392-759) N713I '
  - factor VIIIa A1
  - complexes
  - factor IX activation
  - TF:F7a
  - factor Xa
  - PROCR:Protein C
  - 'argatroban '
  - C1q binding protein
  - 'factor VIIIa A3 C1 C2 polypeptide '
  - SERPINE2:GAG
  - kallikrein:C1Inh
  - Activated protein C
  - PROCR
  - 'F12 T328K(20-328) '
  - 'factor XIa light chain '
  - 'SERPINC1 '
  - peptide
  - 'F8(20-391) S308L '
  - intermediate form
  - prekallikrein:kininogen:C1q binding protein tetramer
  - activated
  - SERPINC1
  - Va:Xa:Factor Xa
  - 'KNG1(19-644) '
  - domain variant
  - 'FGA(20-866) '
  - PROCR:Activated
  - 'F8(20-391) A303E '
  - 'factor VIII heavy chain '
  - (factor IIa)
  - NH4+
  - 'F8(373-581) '
  - binding protein
  - 'F12 T328R '
  - IXa
  - F12 variant
  - Zn2+
  - Xa
  - (factor
  - '11xCbxE-3D-F10(41-179) '
  - A2M tetramer
  - 10xCbxE-F2(44-327)
  license: CC0
  name: Formation of Fibrin Clot (Clotting Cascade)
seo: CreativeWork
title: Formation of Fibrin Clot (Clotting Cascade)
wpid: WP1818
---